Cerebras Went Public. It Immediately Doubled.

Cerebras Systems priced its IPO at $185 per share on the evening of May 13 and opened May 14 on the Nasdaq to a market that had clearly been waiting for it. Shares surged more than 100% on the first day of trading, according to Fortune.

The company sold 30 million shares and raised roughly $5.55 billion. Underwriters hold an option on an additional 4.5 million shares.

A chipmaker that most Americans had never heard of a month ago just pulled in more IPO cash than most companies see in a lifetime.

What Cerebras Actually Does

Founded in 2016 and headquartered in Sunnyvale, California, Cerebras makes AI processors that are physically enormous — a single chip the size of a dinner plate, built from an entire silicon wafer. Most chipmakers dice wafers into hundreds of small chips. Cerebras doesn't.

The company's flagship product, the Wafer Scale Engine 3 (WSE-3), has 250 times more on-chip memory and 2,625 times more memory bandwidth than Nvidia's B200 platform, according to a Cerebras SEC filing cited by Motley Fool.

Nvidia still owns 86% of the AI data center processor market as of end of 2025, per the same filing. Cerebras is gunning for a piece of that.

CEO Andrew Feldman told Fortune the demand for AI inference chips is NOT speculative. His words: "We're not in a situation like 'Field of Dreams,' where 'if you build it, they will come.'" Translation: customers are already here.

OpenAI Is Basically Buying Cerebras

This isn't just a hot IPO story. It's a story about OpenAI locking down its supply chain.

In January, Cerebras signed a $10 billion agreement with OpenAI to supply 750 megawatts of AI infrastructure. Then, just weeks after the IPO, OpenAI signed a second deal — $20 billion over three years for an 11% equity stake in Cerebras, according to Motley Fool.

OpenAI is simultaneously racing toward its own IPO at an $850 billion valuation, per Sharecafe, while becoming a major investor in one of its hardware suppliers. That's a conflict of interest worth watching. Nobody in mainstream financial coverage is asking hard questions about what happens to Cerebras if OpenAI's IPO stumbles.

Wall Street's Concentration Risk

GQG Partners, a global equities firm managing $167 billion in assets, isn't buying the hype uncritically. Portfolio manager Ben Larsen told Sharecafe that indices are going to become "more concentrated" and "more narrowly exposed to the same theme" as these AI mega-caps fast-track onto the Nasdaq and MSCI indices — potentially bypassing standard waiting periods.

The warning is simple: to fund these monster IPOs, investors will sell existing holdings. That puts downward pressure on everything else.

GQG's Chief Investment Officer Rajiv Jain has already labeled the AI stock surge "dotcom on steroids."

Franklin Templeton piled on, warning that a wave of new mega-caps — SpaceX, OpenAI, Anthropic — will compete for capital not just with each other, but with existing publicly traded growth stocks in software, semiconductors, and defense.

Jack Hu, who runs the Phoenix Growth Fund and holds a stake in SpaceX, told Sharecafe the company is "very richly valued" and that he plans to trim.

SpaceX's Numbers Are Getting Scrutinized

Previous coverage flagged SpaceX's filing at a $1.5–1.75 trillion valuation. Larsen at GQG is now specifically calling SpaceX's implied price-to-sales multiple of over 100x "eye-watering." That's a precise, named warning from a serious fund manager.

At 100x sales, you're not buying a company. You're buying a religion.

What Mainstream Media Is Getting Wrong

Most coverage is treating Cerebras's debut as pure good news — a validation of the AI investment cycle. Fortune's framing is celebratory. The Hill calls these IPOs a "new front in the AI race," which is technically true but buries the risk entirely.

OpenAI is an investor in Cerebras, a future competitor to Nvidia, while simultaneously rushing its own IPO. The circular capital flows here — where AI companies fund each other's infrastructure and equity — deserve serious scrutiny, not breathless headlines.

The index concentration problem is real. When SpaceX, OpenAI, and Anthropic all land on major indices, passive fund investors — including millions of Americans with 401(k)s — will be automatically loaded up on AI exposure they didn't choose.

The Cerebras vs. Microsoft Disconnect

Motley Fool raised a comparison worth examining. While Cerebras stock surged dramatically from its IPO price in the days following listing, Microsoft — which actually generates massive AI and cloud revenue — is down more than 8% over the past 12 months.

Cerebras isn't yet consistently profitable. Microsoft reported solid fiscal 2026 Q3 growth and has a dominant cloud and AI position. The market is paying a huge premium for the new shiny thing while ignoring the company that's actually making money from AI today.

What This Means for Regular People

If you have a retirement account tied to index funds, you're about to get a lot more AI exposure whether you want it or not. The fast-tracking of SpaceX, OpenAI, and Cerebras onto major indices isn't just a Wall Street story — it's your 401(k) story.

Cerebras's technology may be genuinely revolutionary. Or it may be a very expensive bet that most of us are funding without realizing it. The people managing your money at firms like GQG are nervous. You should probably know that.